Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer

Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study

(2022) Natalia Valdiviezo et al.   Cancer Management and Research

Socioeconomic status variables contribute to the disparities in female triple negative breast cancer outcome in the United States, 2011-2015: A population study based on NCI Surveillance, Epidemiology and End Results (SEER) database.

(2021) Zikun Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients

(2020) Lifen Cai et al.   Scientific Reports

Impact of the delayed initiation of adjuvant chemotherapy in the outcome of triple-negative breast cancer

(2020) Zaida Morante et al.   Clinical Breast Cancer

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis

(2019) Amanda R. Kupstas et al.   ANNALS OF SURGICAL ONCOLOGY

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

(2019) Olivia Pagani et al.   JOURNAL OF CLINICAL ONCOLOGY

Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer

(2018) Lakisha Moore-Smith et al.   SURGICAL CLINICS OF NORTH AMERICA

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes

(2016) Wai-Ki Yip et al.   Clinical Trials

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials

(2016) Meredith M. Regan et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis

(2016) Xin Victoria Wang et al.   STATISTICS IN MEDICINE

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease

(2016) Joseph A Pinto et al.   npj Genomic Medicine

Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP

(2015) Ann A Lazar et al.   Clinical Trials

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

(2014) Debora de Melo Gagliato et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

(2013) Katherine L. Pogue-Geile et al.   JNCI-Journal of the National Cancer Institute

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience

(2013) O. Metzger-Filho et al.   ONCOLOGIST

A Review of Breast Cancer Care and Outcomes in Latin America

(2013) N. Justo et al.   ONCOLOGIST

Delays in Time to Treatment and Survival Impact in Breast Cancer

(2010) Amy Brazda et al.   ANNALS OF SURGICAL ONCOLOGY

Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database

(2010) Carlos S. Vallejos et al.   Clinical Breast Cancer

Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment Effect Pattern Plot

(2010) Ann A. Lazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple negative breast cancers: Clinical and prognostic implications

(2009) S.J. Dawson et al.   EUROPEAN JOURNAL OF CANCER